Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Assets (2019 - 2026)

Pliant Therapeutics has reported Other Non-Current Assets over the past 8 years, most recently at $1.5 million for Q1 2026.

  • Quarterly Other Non-Current Assets changed 0.0% to $1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, changed 0.0% year-over-year, with the annual reading at $392000.0 for FY2025, 73.55% down from the prior year.
  • Other Non-Current Assets was $1.5 million for Q1 2026 at Pliant Therapeutics, up from $392000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.5 million in Q4 2023 and troughed at $392000.0 in Q3 2025.
  • The 5-year median for Other Non-Current Assets is $1.5 million (2023), against an average of $1.1 million.
  • Year-over-year, Other Non-Current Assets skyrocketed 85.14% in 2022 and then plummeted 73.55% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $397000.0 in 2022, then soared by 273.3% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then plummeted by 73.55% to $392000.0 in 2025, then surged by 278.06% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Other Non-Current Assets are $1.5 million (Q1 2026), $392000.0 (Q4 2025), and $392000.0 (Q3 2025).